In the aftermath of the COVID pandemic, which has left devastating impact on health, the global economy, etc., the world has learned the hard way that in the end, no one is safe until everyone is safe. Vaccines were the the main weapon used in the fight against COVID, and helped many countries extricate themselves from the pandemic’s impact over the past few months. However, we also witnessed the grave imbalance of vaccine access and equity. Hence, local vaccine manufacturing is one of the most important areas considered by many developing countries around the world, especially in LMICs, to overcome vaccine inequity in future.
One of the important resource gaps identified by many experts in enabling local vaccine manufacturing is the availability of skilled, trained personnel in this highly technologically demanding field. To support these countries who want to fill this resource gap, the “Global Bio Manufacturing Workforce Training” was established by the Korean Ministry of Health and Welfare(MOHW) with support from WHO, including WHO Academy.
Training courses are administered by the International Vaccine Institute (IVI), the first of its kind global program supported by the Government of Korea, aim to provide essential, practical knowledge through an intensive short-term program designed to strengthen students’ professional capacity. Accordingly, the new program will include offline and online courses on biologics development and manufacturing, standard practice trainings such as GxP trainings, and onsite training and consultation for biomanufacturers.
The 2023 Introductory Course for Biologics Development and Manufacturing is the first training course under the program Global Training Hub for Biomanufacturing (GTH-B), supported by the South Korean Ministry of Health and Welfare (MoHW) and WHO. It focuses on the training of biomanufacturing workforce not only for Korea but for all Low- and Middle-Income Countries (LMICs) interested in the development of biomanufacturing capacity.
The 2-week course is designed as an introductory training course for the bio manufacturing workforce. It includes basic learnings across various fields related to biologics development and manufacturing. The In-Person course also offers a great chance to network with 150+ vaccine and biomanufacturing professionals worldwide.
Course Information (Offline, Seoul South Korea)
- Course Content: Basic vaccinology for the biomedical workforce
- Course Duration: 10 working days, (2 calendar weeks)
- Faculty: Area-specific experts
- Hours of Training: 80 hours including case study, networking workshop and excursions.
- Excursion Sites: hospital clinical centers, biomedical product development and research sites, manufacturing sites
- Target Trainees: 150 trainees from South Korea and LMICs.
- Certificate of completion: Certificates will be issued if trainee participation exceeds 90% of the whole training, which will be assessed through exams during the course.
The 2023 Introductory Course for Standard Practice (GxP Course) intends to provide training on international standard of quality for vaccine and biomedical product development and manufacturing known as Good Clinical, Manufacturing and Laboratory Practice (GCP, GMP, GLP – together GxP) and the basics of biosafety. Other standards not formalized by the International Committee for Harmonization (ICH) include a guideline for Good Clinical Laboratory Practice (GCLP). Trainees who wish to participate in this course will be required to have up to 6 years of experience in biomanufacturing, or relevant field.
Course Information (Offline, South Korea)
- Course Content: Good clinical, manufacturing, laboratory practice (GCP, GMP, GLP) and biosafety for adherence to international standard of quality in vaccine and biomedical product development.
- Course Duration: 15 working days, (3 calendar weeks)
- Faculty: Area-specific experts
- Hours of Training: 120 hours including hands-on training, excursion, and tests
- Excursion Sites: Hospital clinical centers, biomedical product development and research sites, manufacturing sites
- Target Trainees: 150 trainees from South Korea and Low- and Middle-Income Countries (LMICs).
- Trainee Qualification: Technician, engineer, scientist, and manager with up to 6 years of experience in biomanufacturing, or related experience
- Certificate of completion: Certificates will be issued if trainee participation exceeds 90% of the whole training, which will be assessed through exams.